National Stock Exchange of India completed India's second-largest IPO in September 2026, raising $2.4 billion. The issue price was set at ₹1,785 per share—the upper end of the ₹1,700-1,785 band. The stock listed at ₹1,800, a modest 0.84% premium, and briefly touched ₹1,878 on day one. But the party didn't last. By October 5, 2026, NSE shares were trading at ₹1,741.30—down 2.45% from the IPO price[stock_agent].
This isn't an isolated story.
Collectively, these seven raised ₹1.05 trillion but are now valued 15.3% lower at ₹88,979 crore. Swiggy is down 35%, Paytm's parent is down 22%, and NSE joins this club despite being an exceptional business with 71% EBITDA margins and a fortress balance sheet.
So what went wrong? The answer lies in a mix of valuation, timing, and market structure.
NSE is undeniably a strong business. It handles 92.99% of India's cash market volumes and 99.79% of equity futures. But the IPO was priced at 41-43 times FY2026 earnings—a premium multiple that left little room for error. Independent analysis suggested a fair value around ₹1,565 per share, well below the final issue price of ₹1,785.
The IPO was structured as a pure Offer for Sale (OFS)—no fresh capital, just existing shareholders selling. Some of these sellers, including public sector banks and insurers, had acquired shares at near-zero cost (some under ₹1 per share). At the IPO price, they were sitting on returns measured in thousands of percent. This created a perception of insiders cashing out at peak valuations, which didn't sit well with investors.
Adding to the pressure, NSE's financials showed declining trends. FY2026 revenue fell 3% year-on-year, and net profit dropped 15%. Approximately 79% of operating revenue comes from transaction charges, and SEBI has been actively curbing the equity options segment—NSE's largest profit pool. A pending Supreme Court appeal on the co-location case (despite a proposed ₹1,491 crore settlement) added another layer of uncertainty.
NSE listed on September 24, 2026, right into a market that was already under severe stress. The Nifty 50 recorded its worst September performance in 25 years, falling nearly 6% and losing over 1,400 points during the series. Foreign institutional investors sold heavily, with outflows crossing ₹2.5 lakh crore in 2026.
This wasn't just a routine correction. It was an eight-week losing streak—the longest in 25 years. Twelve Nifty 50 stocks were trading at 52-week lows, including heavyweights like Maruti Suzuki, M&M, ITC, NTPC, HUL, and Reliance Industries. In this environment, even high-quality stocks with premium valuations faced selling pressure.
NSE's decline below IPO price needs to be seen in this context. About 30-40% of the drop can be attributed to systemic market pressures, but the remaining 60-70% is company-specific—primarily the rich valuation and growth concerns [stock_agent].
The decline in NSE didn't happen in isolation. It triggered a cascade in two other stocks: IFCI Ltd and The New India Assurance Company.
IFCI owns 52.86% of Stock Holding Corporation of India (SHCIL), which holds 4.4% of NSE. This gives IFCI an effective indirect exposure of roughly 2.3-2.35% to NSE. NIACL owns a direct 1.42% stake in NSE.
When NSE fell below its IPO price on September 28, 2026, IFCI and NIACL shares came under immediate pressure. Between September 24 and October 1, 2026, NSE fell 4.22%, IFCI plummeted 13.37%, and NIACL dropped 11.20% [stock_agent]. The correlation between NSE and IFCI reached 0.91—near-perfect synchronization [stock_agent].
This isn't just correlation; it's causation. The ownership structures create direct mathematical sensitivity. When NSE's market cap declines, the value of IFCI's and NIACL's holdings drops immediately, forcing a revaluation of both companies. During market stress, this creates self-reinforcing feedback loops where selling in one stock triggers selling in the others, amplifying the decline.
The NSE IPO was guided by an elite legal team: Cyril Amarchand Mangaldas (CAM) advised NSE, Latham & Watkins acted as international counsel, while Khaitan & Co and Sidley Austin advised the book running lead managers. Their mandate was regulatory compliance and disclosure adequacy—not post-listing price support.
The Draft Red Herring Prospectus (DRHP) contained extensive risk disclosures that foreshadowed NSE's vulnerability: pending Supreme Court appeals, regulatory throttling of derivatives, revenue concentration (46.78% from top 10 trading members), and technology/operational risks. But these disclosures were buried beneath impressive headline numbers about market dominance. DRHP +2
The IPO structure itself constrained price stability. As a pure OFS with no fresh capital, NSE had no war chest for buybacks or market-making. Lock-in provisions provided only temporary stability—pre-offer capital is locked for six months, and anchor investors have 30-90 day lock-ins. There's no promoter lock-in because NSE has no identifiable promoter, removing a key source of long-term price support. DRHP +2
For traders, the current environment demands strict risk management. The 1% risk rule is non-negotiable—never risk more than 1% of total trading capital on any single trade. With NSE at ₹1,741.30, a stop loss at ₹1,700 and a ₹2,00,000 capital base means buying only 48 shares.
Position sizing becomes even more critical given the high correlation. If trading NSE, IFCI, and NIACL together, treat them as a single correlated trade. Reduce each position to 0.33% risk (total 1%) rather than 1% each [stock_agent].
For investors, the positioning depends on your view:
NSE: Cautious wait. The stock is still richly valued at 41.62x P/E. Better entry levels exist around ₹1,650-1,700 (major support zone). For long-term investors, accumulate in tranches: 25% at ₹1,700-1,720, 50% at ₹1,650-1,680, and 75% at ₹1,600-1,630 [stock_agent].
IFCI: Speculative proxy. IFCI is essentially a leveraged bet on NSE through its 2.3% indirect exposure. Only consider if you're bullish on NSE and want amplified exposure. For traders, enter above ₹80 with a stop at ₹72, targeting ₹100.
NIACL: Value opportunity. At P/E 4.71x and P/B 0.94x, NIACL is the most attractive fundamentally. The stock has stabilized near its 50-DMA around ₹179. Accumulate between ₹155-165, with a stop at ₹145 and targets of ₹190-200[stock_agent].
NSE's post-listing underperformance is a reminder that "great company" doesn't always equal "great investment" at the wrong price. The IPO was priced for perfection in a market that was about to get ugly. The legal team did their job on compliance, but compliance doesn't protect against market corrections or valuation resets.
For now, patience is the smarter play. NSE's business quality remains intact, but the valuation needs time to reset. IFCI remains a high-risk proxy trade, while NIACL offers the best risk-reward for value investors. The broader lesson? In a market where 7 of 11 blockbuster IPOs are underwater, discipline matters more than hype.
